FIELD: medicine.
SUBSTANCE: invention relates to a combination for the treatment or prevention of HIV-mediated diseases, including therapeutically effective amount of a compound of the formula I and at least one compound selected from a group including HIV protease inhibitors, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, CCR5 antagonists, and inhibitors of viral penetration to a cell, as well as to a method for the treatment or prevention of HIV-mediated diseases.
EFFECT: new combination for the treatment or prevention of HIV-mediated diseases is developed, including therapeutically effective amount of a compound of the formula I and at least one compound selected from a group including HIV protease inhibitors, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, CCR5 antagonists, and inhibitors of viral penetration to a cell, which can be used in the treatment or prevention of HIV-mediated diseases.
17 cl, 68 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL REMEDIES FOR TREATMENT AND PREVENTION OF HIV INFECTION | 2020 |
|
RU2780101C2 |
| TETRAHYDRO-4N-PYRIDO[1,2-a]PYRIMIDINE AND RELATED COMPOUNDS, USED AS INHIBITORS OF HIV-INTEGRASE | 2003 |
|
RU2329265C2 |
| SUBSTITUTED COMPOUNDS OF THIOPHEN AND FURAN-CONDENSED AZOLOPYRIMIDIN-5-(6H)-OH | 2013 |
|
RU2659779C2 |
| Axl INHIBITORS APPLICABLE IN COMBINATION THERAPY FOR PREVENTING, RELIEVING OR TREATING METASTATIC CANCER | 2010 |
|
RU2555326C2 |
| HETEROCYCLIC COMPOUNDS OR THEIR ACID-ADDITIVE SALTS | 1991 |
|
RU2057754C1 |
| CONDENSED PIRIMIDINE DERIVATIVE AND PHARMACEUTICS WITH CRF RELATED ACTIVITY | 2004 |
|
RU2328497C2 |
| SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR TREATING VESTIBULAR DISORDERS | 2009 |
|
RU2589846C2 |
| METHOD FOR PREPARING 5,8,9,10-TETRAHYDROPYRIMIDINO[4,5-d]AZOCINE DERIVATIVES HAVING TRIFLATE, SECONDARY AND TERTIARY AMINO GROUPS IN 4-TH POSITION | 2011 |
|
RU2478637C2 |
| BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
| PYRIDAZINE DERIVATIVES AS RORc MODULATORS | 2017 |
|
RU2757571C2 |
